—

Elmind Capital, LP

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    34

  • Value ($000)

    $352,219

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0002052213
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
C
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$45.06M
13 %

1,170,740

S
SNDX

SYNDAX PHARMACEUTICALS INC

COM
87164F105
$43.33M
12 %

1,855,000

T
TCE2

CELLDEX THERAPEUTICS INC NEW

COM NEW
15117B202
$27.44M
8 %

865,000

C
CTMX

CYTOMX THERAPEUTICS INC.

COM
23284F105
$21.39M
6 %

4,550,000

K
KALV

KALVISTA PHARMACEUTICALS INC

COM
483497103
$20.56M
6 %

1,021,300

C
CGON

CG ONCOLOGY INC

COM
156944100
$19.75M
6 %

291,800

V
VERA

VERA THERAPEUTICS INC

CL A
92337R101
$19.41M
6 %

482,500

P
PCVX

VAXCYTE INC

COM
92243G108
$18.39M
5 %

316,500

---

PHARVARIS N V

COM
N69605108
$13.44M
4 %

475,750

---

TYRA BIOSCIENCES INC

COM
90240B106
$13.41M
4 %

350,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 34